BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23481527)

  • 1. Reinitiation of statins after statin-associated musculoskeletal symptoms: a patient-centered approach.
    Brito JP; Montori VM
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):243-7. PubMed ID: 23481527
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of fibrate-statin combination therapy on cardiovascular events: a retrospective cohort analysis.
    Wierzbicki AS; Morrell J; Hemsley D; McMahon Z; Crook MA; Wray R
    Curr Med Res Opin; 2010 Sep; 26(9):2141-6. PubMed ID: 20662558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Residual risk of cardiovascular complications and its reduction with a combination of lipid lowering agents].
    Soska V
    Vnitr Lek; 2011 Mar; 57(3):313-6. PubMed ID: 21495414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing key questions with statin therapy.
    Toth PP
    J Fam Pract; 2012 Jun; 61(6 Suppl):S34-9. PubMed ID: 22670245
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of statins on renal function].
    Kasahara M
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1295-300. PubMed ID: 24288966
    [No Abstract]   [Full Text] [Related]  

  • 6. Statin Intolerance From a Clinician's Perspective.
    Whayne TF
    Angiology; 2016 Mar; 67(3):205-7. PubMed ID: 26019266
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
    Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins.
    Ratchford EV; Martin SS
    Vasc Med; 2017 Oct; 22(5):442-445. PubMed ID: 28803537
    [No Abstract]   [Full Text] [Related]  

  • 9. US panel recommends statins for adults aged 40 to 75 at 10% or greater risk of cardiovascular disease.
    McCarthy M
    BMJ; 2015 Dec; 351():h7008. PubMed ID: 26715463
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid-lowering agents and new onset diabetes mellitus.
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2010 Aug; 11(12):1965-70. PubMed ID: 20486831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual dyslipidaemia after statin treatment in France: Prevalence and risk distribution.
    Ferrières J; Bérard E; Crisan O; Bongard V
    Arch Cardiovasc Dis; 2010 May; 103(5):302-9. PubMed ID: 20619240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical practice guidelines for the management of dyslipidemia in chronic kidney disease].
    Shoji T
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1267-75. PubMed ID: 24288962
    [No Abstract]   [Full Text] [Related]  

  • 13. Exploring the Management of Statin Intolerant Patients: 2016 and Beyond.
    Katsiki N; Athyros VG; Karagiannis A
    Curr Vasc Pharmacol; 2016; 14(6):523-533. PubMed ID: 26916398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid abnormalities and cardiovascular risk in the elderly.
    Milionis HJ; Elisaf MS; Mikhailidis DP
    Curr Med Res Opin; 2008 Mar; 24(3):653-7. PubMed ID: 18218195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who should receive a statin drug to lower cardiovascular risk? Does the drug and the dose of the drug matter?
    Nixon JV
    Vasc Health Risk Manag; 2006; 2(4):441-6. PubMed ID: 17323598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Questioning the benefits of statins.
    Mazowita G
    CMAJ; 2005 Nov; 173(10):1210; author reply 1210. PubMed ID: 16275979
    [No Abstract]   [Full Text] [Related]  

  • 17. Overcoming Challenges With Statin Therapy.
    Spence JD; Dresser GK
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26819251
    [No Abstract]   [Full Text] [Related]  

  • 18. [Statins and the risk of diabetes].
    Simonyi G
    Orv Hetil; 2013 Oct; 154(43):1691-5. PubMed ID: 24140507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regarding "Perioperative use of statins does not reduce cardiovascular risk".
    Takagi H; Tanabashi T; Kawai N; Umemoto T
    J Vasc Surg; 2007 Aug; 46(2):400-1. PubMed ID: 17664122
    [No Abstract]   [Full Text] [Related]  

  • 20. The new strategy for statins: should you be taking one? Guidelines for taking cholesterol-lowering drugs now target overall risk rather than cholesterol values.
    Harv Heart Lett; 2014 Feb; 24(6):1, 7. PubMed ID: 24804341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.